Paroxetine: Into Oblivion?

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that is approved by the US Food and Drug Administration (FDA) for adult depression, obsessive-compulsive disorder, anxiety disorders, and vasomotor changes of menopause. Nonetheless, its clinical use has recently fallen into disfavor. Moreover, the FDA advised against its use in the child and adolescent population.